Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer

In separate, live virtual events, Michael J. Birrer, MD, PhD, and Jubilee Brown, MD, surveyed participants on the treatment of a postmenopausal woman with stage IVA endometrial cancer after first-line chemotherapy.

Articles in this issue

over 2 years ago

Article

Leon-Ferre Explores Targeting of PIK3CA Alterations in ER+ Breast Cancer

over 2 years ago

Article

Khouri Discusses Selinexor Dosing and Management Approaches for R/R MM

over 2 years ago

Article

George Explores Impact of Risk Status With Cabozantinib/Nivolumab in Advanced RCC

over 2 years ago

Article

Depth of Response With Quadruplet Regimens Considered in Newly Diagnosed Multiple Myeloma

over 2 years ago

Article

Rossetti Reviews Myelofibrosis Risk Stratification and Outcome Data for Pacritinib

over 2 years ago

Article

Practice Updates in Lung Cancer Stem From Biomarker Testing and Up-Front Immunotherapy

over 2 years ago

Article

Bardia Analyzes Treatment for Certain Patients With Advanced Breast Cancer

over 2 years ago

Article

Immunotherapy’s Survival Benefit Opens New Doors in the Adjuvant RCC Setting

Stay up to date on practice-changing data in community practice.

Roundtable Roundup: Treatment for Metastatic pMMR Endometrial Cancer

Articles in this issue

Related to this article

Trending on Targeted Onc

Novel ADCs Show Responses in Ovarian and Cervical Cancer at ESMO 2026

ESMO 2026: ADCs and New Combinations Advance Lung Cancer Care

ESMO 2026: New Data Advance Prostate, Kidney, and Bladder Cancer Care

340B Contract Pharmacy Case Rekindles Scrutiny Over Program Intent

Lenvatinib Plus Pembro Remains Frontline Standard in RCC